These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2455755)

  • 21. Effects of recombinant gamma-interferon on HLA-DR and DQ expression by skin cells in short-term organ culture.
    Messadi DV; Pober JS; Murphy GF
    Lab Invest; 1988 Jan; 58(1):61-7. PubMed ID: 3121914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
    Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
    J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated T cells and monocytes have characteristic patterns of class II antigen expression.
    Robbins PA; Maino VC; Warner NL; Brodsky FM
    J Immunol; 1988 Aug; 141(4):1281-7. PubMed ID: 3135327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ubiquitous expression of HLA-DR antigens on human small intestinal epithelium.
    Chiba M; Iizuka M; Masamune O
    Gastroenterol Jpn; 1988 Apr; 23(2):109-16. PubMed ID: 3290039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial cell HLA-DR antigen and myocyte necrosis in human allograft rejection.
    Rabin BS; Griffith BP; Hardesty RL
    J Heart Transplant; 1985 May; 4(3):293-5. PubMed ID: 3916499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential susceptibility to modulation by recombinant immune interferon of HLA-DR and -DQ antigens synthesized by melanoma COLO 38 cells.
    Giacomini P; Aguzzi A; Ferrone S
    Hybridoma; 1986; 5(4):277-88. PubMed ID: 3100420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Class II MHC antigen expression by cultured human cerebral vascular endothelial cells.
    McCarron RM; Wang L; Cowan EP; Spatz M
    Brain Res; 1991 Dec; 566(1-2):325-8. PubMed ID: 1814549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of HLA-DR, DQ and DP loci on monocytes using monoclonal antibodies].
    Májský A
    Cas Lek Cesk; 1987 Oct; 126(42):1313-6. PubMed ID: 3677160
    [No Abstract]   [Full Text] [Related]  

  • 30. The altered expression of MHC-class II determinants on monocytes of cancer patients.
    Uracz W; Stachura J; Pituch-Noworolska A; Popiela T; Czupryna A; Zembala M
    Cancer Immunol Immunother; 1988; 27(2):171-6. PubMed ID: 2458182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunocytochemical analysis of HLA class II (DR) antigens in liver disease in man.
    Barbatis C; Kelly P; Greveson J; Heryet A; McGee JO
    J Clin Pathol; 1987 Aug; 40(8):879-84. PubMed ID: 3308964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum-mediated inhibition of the interferon-gamma-induced HLA-DR expression on monocytes in patients with psoriasis.
    Volk HD; Koyka I; Goan SR; Gruner S; Fiebig H; Sönnichsen N; Diezel W
    J Invest Dermatol; 1986 Oct; 87(4):524-7. PubMed ID: 3093595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of major histocompatibility complex class II antigens on human keratinocytes.
    Niedecken H; Lutz G; Bauer R; Kreysel HW
    J Am Acad Dermatol; 1988 Dec; 19(6):1030-7. PubMed ID: 2462575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
    Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
    Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro cellular interactions among thyrocytes, T cells and monocytes from patients with Graves' disease.
    Otsubo T; Eguchi K; Shimomura C; Ueki Y; Tezuka H; Ishikawa N; Ito K; Nagataki S
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):282-8. PubMed ID: 3132793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Network regulation in rheumatoid arthritis. Studies of DR+ T cells, anti-DR, antiidiotypic antibodies, and clinical disease activity.
    Searles RP; Savage SM; Brozek CM; Marnell LL; Hoffman CL
    Arthritis Rheum; 1988 Jul; 31(7):834-43. PubMed ID: 3293571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D; Alexander MA; Elder DE; Herlyn MF
    J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of non-lymphoid cells expressing HLA-D region antigens in human fetal gut.
    Spencer J; MacDonald TT; Isaacson PG
    Clin Exp Immunol; 1987 Feb; 67(2):415-24. PubMed ID: 3301095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of HLA-DP serological allodeterminants by the use of radioiodinated DP molecules.
    Tanigaki N; Tosi R; Parodi B; Sorrentino R; Ferrara GB; Strominger JL
    Eur J Immunol; 1987 Jun; 17(6):743-50. PubMed ID: 2439347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous expression of thyroid peroxidase and human leukocyte antigen-DR by human thyroid cells: modulation by thyrotropin, thyroid-stimulating antibody, and interferon-gamma.
    Chiovato L; Lapi P; Mariotti S; Del Prete G; De Carli M; Pinchera A
    J Clin Endocrinol Metab; 1994 Aug; 79(2):653-6. PubMed ID: 7913937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.